Troy E. Messick

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes”.

Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes

PLoS Pathogens(2021)10.1371/journal.ppat.1009618

N/A

0.520DataRank · unranked

31 citations

Chenhe Su, Jason Lamontagne, Nicholas Grams, Fang Lü, Yue Zhang +10 more

EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls

Neurology Neuroimmunology & Neuroinflammation(2023)10.1212/nxi.0000000000200149

N/A

0.500DataRank · unranked

27 citations

Samantha S. Soldan, Chenhe Su, Annaliese Clauze, John F. Cooper, R. Patel +8 more

First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr–Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2814

N/A

0.416DataRank · unranked

15 citations

Zahra Talebi, Elizabeth Winters, Caroline Even, Victor Lee, Maura L. Gillison +8 more

Design of novel and highly selective SARS-CoV-2 main protease inhibitors

Antimicrobial Agents and Chemotherapy(2024)10.1128/aac.00562-24

N/A

0.330DataRank · unranked

8 citations

Ian Tietjen, Nitesh Kumar Nandwana, Joel Cassel, Troy E. Messick, Emery T. Register +9 more

Therapeutic approaches to Epstein–Barr virus cancers

Current Opinion in Virology(2022)10.1016/j.coviro.2022.101260

N/A

0DataRank · unranked

23 citations

Troy E. Messick, Paul M. Lieberman, Samantha S. Soldan

EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer

Gastric Cancer(2021)10.1007/s10120-021-01193-6

N/A

0DataRank · unranked

36 citations

Emma M. Anderson, Drew Frase, Yue Zhang, Lisa Beatrice Caruso, Yin Wang +6 more

Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of VK‐2019, a selective EBNA1 inhibitor

Biomedical Chromatography(2023)10.1002/bmc.5775

N/A

0DataRank · unranked

6 citations

Nicole M. Anders, A. Dimitrios Colevas, Troy E. Messick, Michelle A. Rudek, Michael T. Davis

Phase I/IIa clinical trial of a small molecule EBNA1 inhibitor, VK-2019, in patients with Epstein Barr virus–positive nasopharyngeal cancer with pharmacokinetic and pharmacodynamic correlative studies.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6035

N/A

0DataRank · unranked

4 citations

Michelle A. Rudek, Caroline Even, Victor Lee, Maura L. Gillison, Saad A. Khan +6 more

Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA

Molecules(2020)10.3390/molecules25071760

N/A

0DataRank · unranked

17 citations

Lois Tolvinski, Edward R. Zartler, Anna Moberg, Åsa Frostell, Garry R. Smith +3 more